| Product ID |
Product Name |
CAS# |
Purity |
| Y3308593 |
GSK2850163 (S enantiomer) |
2309519-81-9 |
100% |
| Y3306394 |
ORL1 antagonist 1 |
1174985-59-1 |
97% |
| Y3307004 |
LMPTP INHIBITOR 1 hydrochloride |
2310135-38-5 |
99% |
| Y3107437 |
(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate |
1361390-56-8 |
97% |
| Y3296174 |
Cevipabulin fumarate |
849550-67-0 |
99% |
| Y3131796 |
YF-2 hydrochloride |
1312005-62-1 |
99% |
| Y3131794 |
Cys modifier 1 |
2374314-08-4 |
98% |
| Y3306630 |
anti-TB agent 1 |
2294013-78-6 |
98% |
| Y3309932 |
DSP-0565 |
1226855-28-2 |
97% |
| Y3290055 |
MT-7716 hydrochloride |
1215859-93-0 |
99% |
| Y3304694 |
BuChE-IN-TM-10 |
2313524-95-5 |
99% |
| Y3131803 |
ELX-02 disulfate |
2244622-33-9 |
98% |
| Y3131812 |
NPD-1335 |
2376326-31-5 |
98% |
| Y3297890 |
Methyl Ester N-[6-(3-Cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]carbamic Acid |
2146177-09-3 |
98% |
| Y3304698 |
CS-722 Free base |
749179-13-3 |
97% |
| Y3288081 |
4-[4-(2,5-dioxo-1-phenylpyrrolidin-3-yl)piperazin-4-ium-1-yl]phenolate |
522649-59-8 |
99% |
| Y3304853 |
Cdc7-IN-7 |
1402059-17-9 |
99% |
| Y3310027 |
TP-008 |
1976038-41-1 |
98% |
| Y3288122 |
Cyclo(his-pro) TFA |
936749-56-3 |
99% |
| Y3131829 |
(3S,5R)-Fluvastatin D6 sodium |
2249799-35-5 |
98% |
| Y3298037 |
CFTR corrector 4 |
1918142-34-3 |
99% |
| Y3293700 |
CYP11B2-IN-1 |
1356479-78-1 |
99% |
| Y3294121 |
JH-LPH-28 |
2414592-36-0 |
98% |
| Y3308176 |
N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3-{[4-(trifluoromethyl)phenyl]formamido}propanamide |
2029049-77-0 |
98% |
| Y3310526 |
LpxH-IN-AZ1 |
901260-40-0 |
99% |
| Y3131838 |
potassium1-hydroxypiperidine-2-carboxylate |
2253632-01-6 |
95% |
| Y3291585 |
OSMI-2 |
2260542-60-5 |
98% |
| Y3131837 |
PF-05198007 |
1235406-19-5 |
99% |
| Y3305772 |
OMDM-6 |
616884-67-4 |
99% |
| Y3306098 |
(Rac)-AMG8379 |
1641574-26-6 |
99% |
| Y3131830 |
HSD1590 |
2379279-96-4 |
99% |
| Y3293028 |
Wnt pathway activator 2 |
1360540-82-4 |
98% |
| Y3305839 |
6'-GNTI dihydrochloride |
2410327-94-3 |
98% |
| Y3287803 |
D-3 |
1967815-98-0 |
99% |
| Y3287261 |
MET kinase-IN-2 |
2101241-90-9 |
98% |
| Y3131839 |
Influenza A virus-IN-1 |
2250313-14-3 |
99% |
| Y3311444 |
NITD-916 |
1614262-83-7 |
98% |
| Y3294334 |
FCPR03 |
1917347-65-9 |
99% |
| Y3314790 |
BHQ-2 NHS |
916753-62-3 |
95% |
| Y3287767 |
E235 |
891894-69-2 |
98% |
| Y3307560 |
EMD57439 |
148714-88-9 |
100% |
| Y3131842 |
Hemiasterlin |
157207-90-4 |
99% |
| Y3292220 |
K67 |
2046250-48-8 |
98% |
| Y3305290 |
Zifaxaban |
1378266-98-8 |
100% |
| Y3308610 |
Valategrast hydrochloride |
828271-96-1 |
98% |
| Y3288288 |
UNC9995 |
1354030-52-6 |
99% |
| Y3307644 |
SCH 57790 |
221660-80-6 |
98% |
| Y3305969 |
Seridopidine |
883631-51-4 |
99% |
| Y3295533 |
S 17092 |
176797-26-5 |
98% |
| Y3305131 |
PF-03382792 |
1400811-63-3 |
98% |
| Y3313796 |
PF-03654746 |
935840-31-6 |
99% |
| Y3309062 |
OPC-51803 |
192514-54-8 |
99% |
| Y3306819 |
Ordopidine |
871351-60-9 |
99% |
| Y3297171 |
AMPA receptor modulator-3 |
211311-39-6 |
99% |
| Y3287452 |
LP-471756 |
413605-11-5 |
99% |
| Y3307263 |
Landipirdine |
1000308-25-7 |
99% |
| Y3137078 |
Alirinetide |
725715-18-4 |
99% |
| Y3137081 |
IHVR-11029 |
1383152-30-4 |
99% |
| Y3295926 |
FR194921 |
202646-80-8 |
98% |
| Y3306277 |
FR-167356 |
174185-16-1 |
98% |
| Y3309477 |
Deferitazole |
945635-15-4 |
98% |
| Y3137084 |
PPARd/ agonist 1 sodium |
1258076-66-2 |
99% |
| Y3289026 |
Enflicoxib |
251442-94-1 |
99% |
| Y3137075 |
CP-601932 |
357425-68-4 |
99.74% |
| Y3288887 |
Pomalidomide M16 |
1547162-46-8 |
98% |
| Y3294115 |
ASN06917370 |
837404-68-9 |
99% |
| Y3294842 |
AN0128 |
872044-70-7 |
98% |
| Y3137161 |
ER176 |
1373887-29-6 |
99.77% |
| Y3137214 |
Samelisant |
1394808-20-8 |
98.65% |
| Y3310188 |
Ronacaleret HCl |
702686-96-2 |
100% |
| Y3311092 |
MRT-83 hydrochloride |
1359944-60-7 |
99% |
| Y3310600 |
Kanshone C |
117634-64-7 |
98% |
| Y3317089 |
Morusignin L |
149733-95-9 |
98% |
| Y3310023 |
1,2,3,7-Tetrahydroxy-8-methoxy-6-methyl-9,10-anthraquinone |
130018-57-4 |
98% |
| Y3305324 |
Inonotusol F |
1534433-74-3 |
95% |
| Y3314758 |
Maceneolignan H |
1314042-85-7 |
98% |
| Y3315829 |
Garcinielliptone HD |
1008376-90-6 |
98% |
| Y3315512 |
Campneoside II |
95587-86-3 |
95% |
| Y3312915 |
Peimisine 3-O-β-D-glucopyranoside |
1407161-78-7 |
95% |
| Y3315495 |
Macrostemonoside I |
162413-63-0 |
98% |
| Y3315084 |
2'- O -Acetylthevetin B |
82145-55-9 |
98% |
| Y3305526 |
a-Thevetin B |
144300-21-0 |
98% |
| Y3314612 |
(1β,2β,3β,4β,5β,7α,22α)-27-(β-D-Glucopyranosyloxy)-1,2,3,4,5,7,22-heptahydroxyfurost-25-en-6-one |
1013405-26-9 |
98% |
| Y3314064 |
Flaccidoside III |
140400-67-5 |
98% |
| Y3312769 |
Arborescosidic acid |
325798-51-4 |
90% |
| Y3318453 |
Ladanetin-6-O-β-D-glucopyranoside |
89647-63-2 |
98% |
| Y3313386 |
Cirsiliol 4'-glucoside |
41087-98-3 |
98% |
| Y3313334 |
Ladanetin-6-O-β-（6''-O- acetyl）glucoside |
1256959-27-9 |
98% |
| Y3136497 |
GLP-1R modulator L7-028 |
2648317-95-5 |
98% |
| Y3311414 |
CC618 |
1680204-90-3 |
99% |
| Y3289520 |
3-Pyridinecarboxylic acid, 2-(4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl)ethyl ester |
2254741-41-6 |
90% |
| Y3136522 |
Velufenacin |
1648737-78-3 |
99.46% |
| Y3291091 |
TH10785 |
1002801-51-5 |
99% |
| Y3311375 |
SBI993 |
2073059-56-8 |
99% |
| Y3271055 |
FLT3-IN-10 |
2088735-51-5 |
98% |
| Y3144463 |
NCT-58 |
2411429-33-7 |
99.82% |
| Y3305936 |
Apigenin 6,8-di-C-alpha-L-arabinopyranoside |
73140-47-3 |
98% |
| Y3144433 |
TL8-506 |
1268163-15-0 |
95% |
| Y3292569 |
(4R)-4-Amino-1-pentanol |
1448001-24-8 |
98% |
| Y3315073 |
4-(difluoromethoxy)-3-(trifluoromethyl)benzoic acid |
1489402-88-1 |
97% |